Back

sTTR variability and outcomes in ATTR-CM

11 May 2026 (15:30 - 15:42)
Organised by: Logo
Congress Presentation Part of: Advances in cardiomyopathies Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Senthil Selvaraj

Duke University School of Medicine, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail
BHB/HRS-1893 in non-obstructive hypertrophic cardiomyopathy
Doctor L. Wang (Beijing, CN)
Slides Video
Presentation thumbnail
RESOLVE-HCM: perhexiline on regression of LVH in symptomatic HCM
Professor J. Selvanayagam (Adelaide, AU)
Slides Video
Presentation thumbnail
Dose-dependent effects of aficamten vs metoprolol in MAPLE-HCM
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides Video
Presentation thumbnail
ATTRibute-CM: outpatient worsening heart failure in ATTR-CM
Professor M. Fontana (London, GB)
Slides Video

Access the full session

Session thumbnail
Advances in cardiomyopathies
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Acoramidis improves serum TTR levels in patients with wild-type or variant transthyretin amyloid cardiomyopathy - results from ATTRibute-CM
thumbnail
Congress Presentation
Effect of acoramidis on all-cause mortality, cardiovascular hospitalization and NT-proBNP in variant ATTR-CM - results from ATTRibute-CM
thumbnail
Congress Session
Advances in cardiomyopathies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources